ea0063p589 | Diabetes, Obesity and Metabolism 2 | ECE2019
Ali Omer
, Cook Keziah
, Lee Don
, Shampanier Kristina
, Tuttle Edward
, Bradt Pamela
We report new estimates of the disutility associated with GL and PL, and the quality of life (QoL) impact of leptin replacement therapy (LRT) based on two methods. The first approach estimates utility decrements associated with a range of impairments related to lipodystrophy through a discrete choice experiment (DCE) conducted with members of the general public; the second elicits QoL estimates from 8 PL patients using the SF-36 instrument. To characterize QoL consequences of ...